NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 176 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Azacitidine May 3, 2021 New Technology System Allows Patients To Get A Mammogram And Biopsy... June 30, 2020 Dame Deborah James’ incredible legacy: The Bowelbabe Fund announces first funded... April 5, 2023 EMA Recommends Granting a Marketing Authorisation for Belantamab Mafodotin August 18, 2025 Load more HOT NEWS Encouraging Single-Agent Antitumour Activity of Divarasib Across KRAS G12C-positive Tumours How Cancer Survivorship Has Changed Over 25 Years: An Expert Perspective Bride Diagnosed with Stage IV Triple-Negative Breast Cancer 6 Months Before... Metformin May Affect Risk of Breast Cancer in Women with Type...
